EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study

Pernille L Kjeldsen, Peter Parbo, Kim V Hansen, Joel F A Aanerud, Rola Ismail, Peter H Nissen, Rikke B Dalby, Malene F Damholdt, Per Borghammer, David J Brooks

Aging Brain · 2022 · 2 · 100048

DOI: 10.1016/j.nbas.2022.100048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Brain, 2022. Verfasst von Pernille L Kjeldsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Clinical Medicine, Aarhus University, Denmark. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020, Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer's disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet to be directly investigated in preclinical AD (pAD). We examined how Aβ was distributed in individuals with pAD and MCI using 11C-Pittsburgh Compound B (PiB) PET.

Methods

In this PET study, 79 subjects were retrospectively enrolled, including 34 controls, 24 pAD, and 21 MCI. All subjects underwent APOE genotyping, 11C-PiB PET, MRI, and cognitive testing. We explored differences in Aβ load, Aβ lateralisation, and Aβ distribution, as well as associations between Aβ distribution and cognition.

Results

The Aβ asymmetry index (AI) differed between groups, with pAD having the highest Aβ AI as compared to both controls and MCI. There was no clear Aβ lateralisation in pAD, but there was a non-significant trend towards Aβ being more left-lateralised in MCI. There were no correlations between the cognitive scores and Aβ AI or Aβ lateralisation in pAD or MCI.

Conclusion

The distribution of Aβ is most asymmetrical in pAD, as Aβ first starts accumulating, and it then becomes less asymmetrical in MCI, when Aβ has spread further, suggesting that more pronounced asymmetrical Aβ distribution may be a distinguishing factor in pAD. Longitudinal studies examining the distribution of Aβ across the AD continuum are needed.

Schlagwörter

Stichwörter der Autor:innen

Amyloid depositionAsymmetryPositron emission tomographyPreclinical Alzheimer’s disease

Autor:innen und Institutionen

  • Dept. of Clinical Medicine, Aarhus University, Denmark.
  • Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.
  • Dept. of Nuclear Medicine, Odense University Hospital, Denmark.
  • Dept. of Nuclear Medicine, Vejle, Lillebælt Hospital, Denmark.
  • Dept. of Clinical Biochemistry, Aarhus University Hospital, Denmark.
  • Dept. of Radiology, Section for Neuroradiology, Aarhus University Hospital, Denmark.

Förderung

  • Horizon 2020
  • Horizon 2020 Framework Programme

Zitieren

APA

Kjeldsen, P. L., Parbo, P., Hansen, K. V., Aanerud, J. F. A., Ismail, R., Nissen, P. H., Dalby, R. B., Damholdt, M. F., Borghammer, P., & Brooks, D. J. (2022). Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study. Aging Brain, 2, 100048. https://doi.org/10.1016/j.nbas.2022.100048

Vancouver

Kjeldsen PL, Parbo P, Hansen KV, Aanerud JFA, Ismail R, Nissen PH, et al. Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study. Aging Brain. 2022;2:100048. doi:10.1016/j.nbas.2022.100048

BibTeX
@article{Kjeldsen2022,
  author = {Kjeldsen, Pernille L and Parbo, Peter and Hansen, Kim V and Aanerud, Joel F A and Ismail, Rola and Nissen, Peter H and Dalby, Rikke B and Damholdt, Malene F and Borghammer, Per and Brooks, David J},
  title = {Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study},
  journal = {Aging Brain},
  year = {2022},
  volume = {2},
  pages = {100048},
  doi = {10.1016/j.nbas.2022.100048}
}
Kostenlos starten →